Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Highlights in colorectal cancer at ASCO GI 2024

In this week’s podcast by VJ Oncology, six leading experts share their insights on cutting-edge developments in colorectal cancer screening…

Date: 8th March 2024

Targeted therapies for lung cancer at TTLC 2024

This week, we cover interesting research from TTLC 2024, focusing on innovative treatments for lung cancer. Starting off, Bruna Pellini…

Date: 1st March 2024

Highlights in colorectal cancer at ASCO GI 2024

In this week’s podcast by VJ Oncology, six leading experts share their insights on cutting-edge developments in colorectal cancer screening…

Date: 8th March 2024

Targeted therapies for lung cancer at TTLC 2024

This week, we cover interesting research from TTLC 2024, focusing on innovative treatments for lung cancer. Starting off, Bruna Pellini…

Date: 1st March 2024

Updates in invasive lobular carcinoma (ILC)

Invasive lobular carcinoma (ILC) poses unique challenges in breast cancer management. Its subtle presentation and distinct biological behavior demand a…

Date: 23rd February 2024

Esophageal and gastric cancer highlights from ASCO GI 2024

In this podcast, we will discuss key insights from the 2024 ASCO Gastrointestinal (GI) Cancers Symposium held in San Francisco,…

Date: 16th February 2024

Key updates at ASCO GU 2024

In this podcast, we will discuss key insights from the 2024 ASCO Genitourinary (GU) Cancers Symposium held in San Francisco,…

Date: 9th February 2024

Highlights in bladder and prostate cancer at PROCSA/BLADDR 2023

In this podcast, we’ll be covering highlights from the PROCSA/BLADDR 2023 Meeting, which took place in Valencia, Spain, such as…

Date: 2nd February 2024

Key updates at ESMO Asia 2023

The recent European Society for Medical Oncology (ESMO) Asia 2023 Congress in Singapore, brought together key oncology experts to delve…

Date: 26th January 2024

Breast Cancer Sessions: Highlights from SABCS 2023 with Sara Tolaney, Sarah Sammons & Paolo Tarantino

The San Antonio Breast Cancer Symposium (SABCS) 2023 took place on the 5-9th of December 2023 in San Antonio, TX….

Date: 12th January 2024

Updates in GI cancer at ESMO 2023

The European Society for Medical Oncology (ESMO) Congress 2023 brought together leading experts to explore and deliberate on the most…

Date: 5th January 2024

2023 updates in metastatic colorectal cancer genomic biomarkers

Huge advancements in personalized medicine and the availability of genetic testing have led us to consider the use of genomic…

Date: 22nd December 2023

Highlights in cancer nursing at UKONS 2023

The 2023 UK Oncology Nursing Society (UKONS) meeting, which took place in Newport, Wales, gathered leading oncology experts to discuss…

Date: 1st December 2023

Highlights in gynecologic cancer from ESMO 2023

The European Society for Medical Oncology (ESMO) Congress 2023 gathered prominent experts to discuss the latest research and breakthroughs in…

Date: 24th November 2023

Highlights in breast cancer from ESMO 2023

The European Society for Medical Oncology (ESMO) Congress 2023, which took place in Madrid, Spain, gathered internationally acclaimed experts to…

Date: 17th November 2023

Highlights in lung cancer from ESMO 2023

The European Society for Medical Oncology Annual Meeting (ESMO) 2023 brought together thousands of experts in oncology to hear new…

Date: 10th November 2023

Highlights in GU cancer at ESMO 2023

The European Society for Medical Oncology (ESMO) Congress 2023, which took place in Madrid, Spain, gathered internationally acclaimed experts to…

Date: 3rd November 2023

EGFR exon 20 insertions and how to manage patients in the UK

EGFR exon 20 insertion mutations represent 5% to 10% of EGFR mutations in patients with non-small cell lung cancer (NSCLC)….

Date: 13th October 2023

Updates in immunotherapy for brain tumors

Even with aggressive surgical procedures, radiation therapy, and systemic chemotherapy, the outlook for individuals diagnosed with malignant brain tumors remains…

Date: 15th September 2023

Developments in Radiotherapy for GI Cancer

For various gastrointestinal (GI) malignancies such as gastric and pancreatic cancer, chemotherapy and surgery remain the standard of care. Numerous…

Date: 8th September 2023

Latest advances in early-stage breast cancer

Over the last decades, systemic therapy for patients with early-stage breast cancer has undergone remarkable enhancements, with the objectives and…

Date: 25th August 2023

Applications of AI in Oncology

Cancer plays a substantial role in worldwide mortality, accounting for approximately 9.3 million deaths each year. Despite considerable strides made…

Date: 18th August 2023

Targeted radionuclide therapy in prostate cancer

Prostate cancer stands as the most frequently detected malignant condition among men, ranking as the second primary contributor to cancer-linked…

Date: 11th August 2023

Latest updates in mesothelioma

In this latest episode from VJOncology, join us as we explore the latest news in mesothelioma research with three distinguished…

Date: 4th August 2023

iwCAR-T Session V: Advances in head & neck and CNS cancers

The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April 2023, and brought…

Date: 28th July 2023

Highlights in GI cancer from ESMO WCGIC 2023

The ESMO World Congress on Gastrointestinal Cancer (WCGIC) 2023 brought together world-renowned experts in oncology to present and discuss the…

Date: 21st July 2023

Updates in immunotherapy for head and neck cancer

In this podcast we’ll be covering some of the latest updates in immunotherapy for head and neck cancer. Ezra Cohen,…

Date: 14th July 2023

iwCAR-T session VI: Advances in GI cancers

The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April 2023, and brought…

Date: 7th July 2023

Highlights in bladder cancer at ASCO 2023: NORSE, RAGNAR, and THOR

In this episode, we will be covering highly anticipated updates in urothelial carcinoma presented at the American Society of Clinical…

Date: 30th June 2023

ASCO 2023 Highlights: THOR, INDIGO and ADAURA

The American Society of Clinical Oncology Annual Meeting 2023 brought together thousands of experts in oncology to hear new data…

Date: 23rd June 2023

iwCAR-T Session III: CAR-T clinical advances in lung cancer

The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April 2023, and brought…

Date: 16th June 2023

iwCAR-T Session II: Cell therapies in GU cancers

The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April 2023, and brought…

Date: 25th May 2023

iwCAR-T Session I: Emerging CARs and future challenges in solid tumors

The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April, 2023, and brought…

Date: 19th May 2023

Highlights at AACR 2023: mRNA vaccines in melanoma and novel RAF inhibitors

In this podcast, we’ll be covering highlights from the American Association for Cancer Research (AACR) Annual Meeting 2023 in Orlando,…

Date: 9th May 2023

Liquid biopsy in lung cancer: precision medicine and MRD

In this podcast, we’ll be discussing the use of liquid biopsy in lung cancer, with Professor Klaus Pantel of University…

Date: 28th April 2023

St. Gallen highlights: controversies in the axilla

In this podcast, Icro Meattini (University of Florence, Florence, Italy) and Orit Kaidar-Person (Sheba Medical Center, Ramat Gan, Israel) discuss…

Date: 14th April 2023

Radiotherapy Highlights from ASCO GU 2023 with Sophia Kamran, Himanshu Nagar, and Neha Vapiwala

In this podcast, hear from GU cancer experts Sophia Kamran (Massachusetts General Hospital and Harvard Medical School, Boston, MA), Himanshu…

Date: 6th April 2023

Chemotherapy, post-adjuvant therapy, and clinical trial ethics at St Gallen BCC 2023

The St Gallen Breast Cancer Congress took place on the 15-18 March 2023. Leading researchers and experts were brought together…

Date: 31st March 2023

Key Trials from ASCO GU 2023 with Scott Tagawa, Karie Runcie, and Tanya Dorff

In this episode, join GU cancer experts Scott Tagawa (Weill Cornell Medicine and New York Presbyterian, New York City, NY),…

Date: 24th March 2023

Biomarkers, patient selection, and immunotherapy at ESMO Gynae 2023

In this episode, we’ll hear from Marcia Hall, Eric Pujade-Lauraine, and Mansoor Raza Mirza, who will share their expertise and…

Date: 17th March 2023

Hot Topics in Renal Cell Carcinoma and Rare Tumors

In this podcast we’ll hear from experts in GU cancer on some of the most exciting clinical trial data in…

Date: 10th March 2023

Key data and hot topics in prostate cancer at ASCO GU 2023

In this episode, we’ll be hearing from GU cancer experts about some of the biggest prostate cancer data presented at…

Date: 3rd March 2023

Hot Topics in Bladder Cancer at ASCO GU 2023

In this podcast, we dive deep into some of the most exciting advances in bladder cancer research that were presented…

Date: 24th February 2023

Approaches to NSCLC with or without targetable mutations

In this podcast, we will explore approaches to non-small cell lung cancer (NSCLC) with and without targetable mutations. NSCLC is…

Date: 17th February 2023

CAR-T in solid tumors: advances and challenges in targeting CLDN18.2, HER2 and STEAP 1

Whilst CAR-T cell therapies have found considerable success in targeting hematological malignancies, major hurdles remain in the solid tumor space….

Date: 10th February 2023

ASCO GI 2023: Bile duct cancer updates with Ghassan Abou-Alfa

In this episode, we are joined by Professor Ghassan Abou-Alfa of Memorial Sloan Kettering Cancer Center. Professor Abou-Alfa is a…

Date: 3rd February 2023

Breast Cancer Sessions: Highlights from SABCS 2022 with Sara Tolaney, Paolo Tarantino & Sarah Sammons

The San Antonio Breast Cancer Symposium (SABCS) 2022 took place on the 6-10th of December 2022 in San Antonio, TX….

Date: 25th January 2023

Updates in cervical cancer

January is Cervical Cancer Awareness month, so for this podcast, we’ve collected the latest updates from our interviews with leading…

Date: 20th January 2023

Resistance to immune checkpoint inhibitors in NSCLC

In this podcast, we’ll be covering the latest updates on immune checkpoint inhibitor resistance for patients with non-small cell lung…

Date: 13th January 2023

Impact of race on breast cancer outcomes

Breast cancer is one of the leading causes of cancer mortality, with incidence, pathology, and clinical outcomes varying by geographical…

Date: 6th January 2023

Immunotherapy updates in GI cancer

Gastrointestinal (GI) cancers have a high incidence rate and is the leading cause of cancer-related mortality. Despite current combinational treatment…

Date: 23rd December 2022

Updates from ESMO Asia 2022

The ESMO Asia 2022 congress took place on the 2nd to the 4th of December in Singapore. We heard from…

Date: 16th December 2022

Updates in EGFR-mutant NSCLC

A large proportion of patients with non-small cell lung cancer (NSCLC) have mutations in EGFR, making it a popular target…

Date: 2nd December 2022

UKONS 2022: cancer care in the digital age

The UKONS Annual Conference took place on 11th and 12th November 2022 in Belfast, Ireland. Leading experts gave updates on…

Date: 25th November 2022

Updates in immunotherapy from SITC 2022

The 37th Annual Meeting of the Society for Immunotherapy in Cancer (SITC) took place on the 8th-12th of November 2022…

Date: 18th November 2022

Advances in radiotherapy from ASTRO 2022

The ASTRO 2022 Annual Meeting took place on the 23-26th October 2022, in San Antonio, TX. Leading experts gave updates…

Date: 16th November 2022

Immunotherapy Updates in Head & Neck Cancer

Head and neck squamous cell carcinoma (HNSCC) is the most prevalent form of head and neck cancer and is typically…

Date: 4th November 2022

Evolving role of ctDNA in breast cancer

With the advent of next-generation sequencing technologies, circulating tumor DNA (ctDNA) has now become an important player in the diagnosis,…

Date: 26th October 2022

Updates in Immuno-Oncology from ITOC 2022

The Immunotherapy of Cancer Conference (ITOC) 2022 brought together experts in the field of immuno-oncology to hear the latest findings…

Date: 24th October 2022

ESMO 2022: Updates in Sarcoma

The European Society for Medical Oncology Annual Meeting 2022 brought together thousands of experts in oncology to hear new data…

Date: 14th October 2022

GI Cancer Sessions: ESMO Highlights with Geoffrey Ku and Sam Klempner

Following an exciting day at the ESMO 2022 meeting in Paris, France, leading gastrointestinal cancer experts get together to share…

Date: 12th October 2022

Breast Cancer Sessions: Highlights from ESMO 2022 with Elisa Agostinetto & Evandro de Azambuja

The European Society for Medical Oncology (ESMO) Annual Meeting, showcased an array of updates in breast cancer care and management,…

Date: 10th October 2022

ESMO 2022: Updates in Colorectal Cancer

The European Society for Medical Oncology Annual Meeting 2022 brought together thousands of experts in oncology to hear new data…

Date: 30th September 2022

ESMO 2022: Updates in Breast Cancer

The European Society for Medical Oncology Annual Meeting 2022 brought together thousands of experts in oncology to hear new data…

Date: 26th September 2022

ESMO 2022 Daily Round-Ups: Day 4

Catch up on our highlights from Day 4 of ESMO 2022! We spoke to Toni Choueiri, Erika Hamilton, Jonathan Rosenberg,…

Date: 12th September 2022

ESMO 2022 Daily Round-Ups: Day 3

Catch up on our highlights from Day 3 of ESMO 2022! We spoke to Fabrice Andre, Fred Saad, and Solange…

Date: 12th September 2022

ESMO 2022 Daily Round-Ups: Day 2

Catch up on our highlights from Day 2 of ESMO 2022! We spoke to Dirk Schadendorf, Bjorn Henning Gronberg, Oleg…

Date: 11th September 2022

The Lung Cancer Sessions: Updates from WCLC 2022

The Lung Cancer Sessions from VJOncology aim to provide interesting perspectives from leading experts on the big topics in lung…

Date: 2nd September 2022

TILs, Cancer Vaccines & the Future of Cellular Therapies in Melanoma with Allison Betof Warner

Immunotherapy plays a vital role in the management of patients with advanced-stage melanoma, and more recently, adoptive cell therapies and…

Date: 26th August 2022

Updates in lung cancer from WCLC 2022

The International Association for the Study of Lung Cancer (IASLC) held their World Congress in Lung Cancer (WCLC) in Vienna,…

Date: 19th August 2022

Updates in Checkpoint Inhibitors for Kidney Cancer

The advent of immune checkpoint inhibitors as a distinct class of immunotherapy has made a large impact within the field…

Date: 12th August 2022

iwCART Sessions: CAR-T clinical advances in breast and ovarian cancer

The International Workshop on CAR-T (iwCAR-T) 2022 featured many updates on the development of CAR-T therapies for the treatment of…

Date: 5th August 2022

Clinical Applications of ctDNA in Oncology

Circulating tumor DNA (ctDNA) are small fragments of nucleic acid that are released into the circulating system via multiple mechanisms…

Date: 29th July 2022

iwCART Sessions: CAR-T clinical advances in lung cancer

The International Workshop on CAR-T (iwCAR-T) 2022 featured many updates on the development of CAR T-cell therapies for the treatment…

Date: 22nd July 2022

ASCO 2022: Updates in Gastrointestinal Cancer

The American Society of Clinical Oncology Annual Meeting 2022 brought together thousands of experts in oncology to hear new data…

Date: 15th July 2022

ASCO 2022: Updates in Genitourinary Cancer

The American Society of Clinical Oncology Annual Meeting 2022 brought together thousands of experts in oncology to hear new data…

Date: 8th July 2022

ASCO 2022: Updates in Breast Cancer

The American Society of Clinical Oncology Annual Meeting 2022 brought together thousands of experts in oncology to hear new data…

Date: 1st July 2022

ASCO 2022: Updates in Lung Cancer

The American Society of Clinical Oncology Annual Meeting 2022 brought together thousands of experts in oncology to hear new data…

Date: 24th June 2022

iwCAR-T Sessions: emerging CARs & challenges in solid tumors

This year’s International Workshop on CAR-T (iwCAR-T) featured a whole day on the development of CAR T-cell therapies in solid…

Date: 17th June 2022

ASCO 2022 Daily Round-Ups: Day 3

Catch up on our highlights from Day 3 of ASCO 2022! We spoke to Jean-Pierre Gerard, Jonathan Rosenberg, Eva Segelov,…

Date: 5th June 2022

ASCO 2022 Daily Round-Ups: Day 2

Catch up on our highlights from Day 2 of ASCO 2022! We spoke to Joaquim Bellmunt, Robert Jones, Miguel Garcia-Pardo,…

Date: 4th June 2022

ASCO 2022 Daily Round-Ups: Day 1

Catch up on our highlights from Day 1 of ASCO 2022!   We spoke to Alexander Spira, Jia Luo, Paolo…

Date: 4th June 2022

Updates in radiation oncology from ESTRO 2022

This year’s European Society for Radiotherapy and Oncology (ESTRO) annual congress took place in Copenhagen, Denmark, from 6-10 May 2022,…

Date: 27th May 2022

Breast Cancer Sessions: Treatment de-escalation in TNBC

The development of complex and effective therapies has improved outcomes in breast cancer, highlighting the need for strategies to escalate…

Date: 20th May 2022

Trial updates from ESMO Breast Cancer 2022: TUXEDO-1, monarchE, KEYNOTE-355

The European Society for Clinical Oncology (ESMO) Breast Cancer Conference was a hybrid event, held virtually and Berlin, Germany. This…

Date: 16th May 2022

Updates in GI cancers from AACR 2022

This year’s American Association for Cancer Research (AACR) congress took place in New Orleans, LA, from 8-13 April 2022, and…

Date: 6th May 2022

Expanding use of artificial intelligence (AI) in oncology

Improvements in early detection, diagnosis, and management have decreased cancer-related mortality, however, challenges associated with personalized care remain. Artificial intelligence…

Date: 29th April 2022

The evolving role of nurses amidst global pandemic: perspectives, and highlights from cancer nursing leaders

In a world that is still acclimatizing to the COVID-19 pandemic, the fragility of many aspects of our society has…

Date: 22nd April 2022

The GU Cancer Sessions: Prostate & kidney cancer at ASCO GU 2022

In this podcast, we hear from genitourinary (GU) cancer experts Tian Zhang, MD, Duke Cancer Center, Durham, NC, and Scott…

Date: 11th April 2022

Lung Cancer Screening: Current state and future directions

Lung cancer is one of the most common cancers in the world, and has a very low survival rate, partly…

Date: 1st April 2022

Novel treatment approaches in HR+/HER2- breast cancer

Resistance to endocrine therapy in patients with hormone-receptor positive (HR+), HER2-negative breast cancer inevitably results in relapse and metastasis, leading…

Date: 25th March 2022

New treatment approaches for advanced or metastatic urothelial carcinoma

Clinical trials presented at the the American Society of Clinical Oncology (ASCO) Genitourinary Cancers (GU) Symposium 2022 have been investigating…

Date: 18th March 2022

The Breast Cancer Sessions: Highlights from SABCS 2021

The San Antonio Breast Cancer Symposium (SABCS) 2021 saw ground-breaking data and developments in breast cancer being presented and in…

Date: 11th March 2022

The GI Cancer Sessions: Highlights from ASCO GI 2022

In this episode of the VJOncology podcast, a panel of leading gastrointestinal (GI) cancer experts offer their perspectives on the…

Date: 4th March 2022

Prostate Cancer Highlights from ASCO GU 2022

The ASCO Genitourinary (GU) Cancers Symposium took place on the 17-19th February 2022, in San Francisco, CA. Leading experts gave…

Date: 25th February 2022

Updates on HER2-positive breast cancer

HER2-positive breast cancer accounts for 15-20% of all breast cancer cases. It was associated with a poor prognosis until the…

Date: 15th February 2022

BTOG 2022: Highlights in lung cancer

For patients with lung cancer, surgical resection is a treatment option and perioperative management is imperative to improve surgical outcomes….

Date: 11th February 2022

The multidisciplinary use of ctDNA in gastrointestinal cancers

Gastrointestinal (GI) cancer remains one of the leading cause of global cancer mortality. The current standard for diagnosing GI cancers…

Date: 2nd February 2022

SITC 2021: Updates on the use of cellular therapies in solid tumors

Cellular immunotherapy approaches have proven to be highly effective in the treatment of patients with hematological malignancies over recent years….

Date: 19th January 2022

Breast Cancer Sessions: Highlights from SABCS 2021 with Lisa Carey & Aleix Prat

The San Antonio Breast Cancer Symposium 2021 featured exciting developments in early and advanced breast cancer, basic science, and translational…

Date: 14th January 2022

Immunotherapy updates from SABCS 2021 with Heather McArthur & Kevin Kalinsky

The success of immunotherapy in the treatment of solid tumors has created hope for its potential in breast cancer. The…

Date: 4th January 2022

The Lung Cancer Sessions: Advances in EGFR-mutated NSCLC

The Lung Cancer Sessions from VJOncology aim to provide interesting perspectives from leading experts on the big topics in lung…

Date: 25th November 2021

ISLB 2021: Current standards and future directions for liquid biopsy

Liquid biopsy is an exciting field, with many promising advances in recent years. In this podcast, we cover a range…

Date: 12th November 2021

Prostate Cancer Highlights from ESMO 2021 with Robert Jones

The European Society for Medical Oncology (ESMO) 2021 Congress saw many exciting clinical trials presented from across the field of…

Date: 28th October 2021

The GU Cancer Sessions: Bladder Highlights from ESMO 2021

VJOncology has assembled a group of leading genitourinary cancer experts to examine and discuss the latest developments in bladder cancer…

Date: 19th October 2021

The Skin Cancer Sessions: Highlights from ASCO 2021

VJOncology has assembled a panel of world-renowned skin cancer experts to examine and discuss the exciting advances in skin cancer…

Date: 7th October 2021

The Lung Cancer Sessions: Highlights from ASCO 2021

Following the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting, VJOncology brought together a group of leading lung cancer…

Date: 7th October 2021

The GI Cancer Sessions: Highlights from ASCO 2021

At the virtual 2021 American Society of Clinical Oncology (ASCO) 2021 Annual Meeting, important advances and potentially practice-changing trial data…

Date: 7th October 2021

Key clinical trial data in urothelial carcinoma at ASCO 2021

Chemotherapy is central to the treatment of advanced or metastatic urothelial carcinoma (UC), and platinum-based treatments, like cisplatin, have been…

Date: 10th September 2021

Prostate Cancer Highlights from ASCO 2021 with Pedro Barata

This year, at the American Society of Clinical Oncology (ASCO) Virtual Meeting 2021, experts came together virtually to present and…

Date: 23rd August 2021

The Breast Cancer Sessions: Highlights from ASCO 2021

VJOncology has assembled an international panel of leading breast cancer experts to discuss the latest advances and data from the…

Date: 18th August 2021

The GU Cancer Sessions: Bladder and Kidney Highlights from ASCO 2021

During the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting, an exciting array of advances in genitourinary (GU) cancer…

Date: 18th August 2021

ASCO 2021: Immunotherapy updates in lung cancer

Various immunotherapies including checkpoint inhibitors have emerged as effective treatment options for patients with non-small cell lung cancer (NSCLC). Immune…

Date: 4th August 2021

EAU 2021: updates in testicular cancer

Whilst advances in diagnostic procedures, radiotherapies, cisplatin-based chemotherapy, and surgery have meant that testicular cancer is curable in around 95%…

Date: 28th July 2021

Highlights from ESMO WCGIC 2021: VALENTINO, KEYNOTE-811 & BEACON-CRC

The ESMO World Congress on Gastrointestinal Cancer (WCGIC) 2021 annual meeting took place virtually this year and leading experts came…

Date: 15th July 2021

What’s new? Treating breast cancer with brain metastases

Metastatic breast cancer is breast cancer that has spread to other regions of the body, most commonly the liver, brain,…

Date: 13th July 2021

Global breast cancer care

Healthcare systems around the world differ in financial and political situations. Therefore, it is vital to implement a global outlook…

Date: 13th July 2021

Latest developments in immunotherapy for patients with melanoma

Surgery is an effective treatment for non-metastatic melanoma, however, advanced melanoma demands additional intervention, such as chemotherapy or immunotherapy. The…

Date: 1st July 2021

ASCO 2021: PSMA-targeted radionuclide therapy for prostate cancer

Prostate-specific membrane antigen (PSMA) is overexpressed in more than 80% of prostate cancer tumors, making it a promising diagnostic and…

Date: 25th June 2021

The Lung Cancer Sessions: Highlights from BTOG 2021

VJOncology has assembled a panel of leading experts, who offer their perspectives on the latest developments in lung cancer presented…

Date: 22nd June 2021

ESMO Breast 2021: updates on immunotherapy

Breast cancer is the most common type of cancer in women. Although most cases of early-stage non-metastatic disease are curable…

Date: 10th June 2021

The GU Cancer Sessions: Bladder and Kidney Highlights from ASCO GU 2021

VJOncology has assembled a panel of leading experts, who offer their perspectives on the latest bladder and kidney cancer data…

Date: 14th May 2021

Sequencing HER2-targeting therapies in the metastatic breast cancer space

Treatment approaches in breast cancer are multimodal, and with the onset of novel immunotherapies and targeted agents, the therapeutic landscape…

Date: 14th May 2021

Latest news in GU: CAR-T in RCC, updates from IMvigor130, & liquid biopsies in prostate cancer

The American Association for Cancer Research Annual Meeting 2021 (AACR) took place virtually this year and showcased an array across…

Date: 13th May 2021

The GU Sessions: Prostate Cancer Highlights from ASCO GU 2021

The 2021 American Society of Clinical Oncology (ASCO) Genitourinary Cancer Symposium showcased a range of exciting clinical trial data and…

Date: 13th May 2021

BTOG 2021: KRAS targeting and oncogenically-driven lung cancer

Traditional treatments for lung cancer include chemotherapy, radiotherapy and surgery, however the identification of oncogenic drivers, such as EGFR, ALK…

Date: 12th May 2021

The Breast Cancer Sessions: a focus on the St. Gallen Consensus

At the 17th St. Gallen International Breast Cancer Conference 2021, leading experts gathered virtually to take part in the renowned…

Date: 26th April 2021

Predictive and prognostic biomarkers in breast cancer

Following a breast cancer diagnosis, the most immediate challenges in patient management are the determination of prognosis and identification of…

Date: 7th April 2021

The Lung Cancer Sessions: highlights from IASLC WCLC

VJOncology has assembled an international panel of leading experts in lung cancer and mesothelioma to bring you the key highlights…

Date: 18th February 2021

The GI Cancer Sessions: Highlights from ASCO GI 2021

The virtual American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2021 brought together leading experts in GI cancer who…

Date: 12th February 2021

The Breast Cancer Sessions: Highlights from SABCS 2020

The virtual San Antonio Breast Cancer Symposium (SABCS) 2020 brought together leading experts in breast cancer who updated the community…

Date: 25th January 2021

SABCS 2020 highlights: immunotherapy, novel agents & trial updates

In December, the San Antonio Breast Cancer Symposium (SABCS) 2020 convened virtually and featured key updates in the treatment and…

Date: 8th January 2021

Key trial updates at SABCS 2020: monarchE, RxPONDER & ASCENT

The San Antonio Breast Cancer Symposium (SABCS) 2020 annual meeting took place virtually this year and showcased recent advances in…

Date: 15th December 2020

Updates in non-small cell lung cancer from ESMO

Significant advances have been made in the treatment of non-small cell lung cancer (NSCLC), the most common form of lung…

Date: 3rd November 2020

Highlights from EADO 2020: novel therapies, neoadjuvant approaches & COVID-19

The 16th European Association of Dermato-Oncology (EADO) meeting took place virtually this year and provided an opportunity to hear from…

Date: 29th October 2020

The Lung Cancer Sessions: learnings from the ESMO 2020 Science Weekend

The European Society for Medical Oncology (ESMO) 2020 Virtual Congress brought together leading experts in oncology who updated the community…

Date: 14th October 2020

The ONS/EONS Congress Roundtable Discussion with VJOncology and OncoAlert

The treatment of cancer continues to evolve rapidly, with expanded therapeutic options and changes to clinical practice. Additionally, the care…

Date: 10th September 2020

Prioritizing patients for breast cancer surgery during COVID-19

Patients with cancer consistently demonstrate poorer post-COVID-19 infection outcomes, and as a result of the pandemic, cancer services within the…

Date: 3rd August 2020

Genotyping in lung cancer and multi-cancer detection

Using precision genotyping for identifying resistance mechanisms in advanced lung cancer can help guide treatment decisions and prolong the benefit…

Date: 1st July 2020

Molecular testing for lung cancer in the UK

Molecular testing for lung cancer mutations plays an important role in the care of patients, by enabling quicker access to…

Date: 13th May 2020

Living with and beyond cancer: a patient’s quality of life is just as important as survival

The views of patients with cancer, and their survivorship, is becoming increasingly important to cancer research. This podcast not only…

Date: 4th February 2019

Advancing immunotherapy for solid tumors

Immunotherapy has the potential to treat all types of cancer, making it a highly lucrative area of research. Since the…

Date: 23rd November 2018

Updates in breast cancer: recent clinical trials, immunotherapy, challenges & future treatment outlook

This is an exciting time in the breast cancer field, with advances in the development of treatments and knowledge regarding…

Date: 11th October 2018

Hot topics in oncology: precision medicine, biomarkers & immunotherapy

In preparation for the ESMO 2018 congress, we’ve put together a series of hot topics in oncology summing up themes…

Date: 14th September 2018

Bladder cancer: advances in the spotlight and what these mean for therapy

Over the past few years, the field of bladder cancer has seen an array of exciting clinical advancements, ranging from…

Date: 16th August 2018